Ireland· IE-PA-PA0074/015/001
MEFAC 250 mg hard capsules
A mefenamic acid product containing mefenamic acid, registered in Ireland by Rowa Pharmaceuticals Limited,. The same ATC class is registered in 7 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Mefenamic acid is registered in 7 of 19 countries.
Countries holding a registration under ATC M01AG01 (mefenamic acid), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Mefenamic acid · ATC M01AG01
7 / 19 countries
- Canada
- Finlandprice
- Ireland
- Japan
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mefenamic acid costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mefenamic acid · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.48
The record
At a glance
HPRA (Ireland)- Active substance
- Mefenamic acid
- Manufacturer
- Rowa Pharmaceuticals Limited,
- Country
- Ireland (IE)
- ATC code
- M01AG01
- ATC class
- Mefenamic acid
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0074/015/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for mefenamic acid.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mefenamic acid · interactions on record
335 records
- 57 severe
- 156 moderate
- 16 minor
- 24 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
82 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mefenamic acid in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDysman 250 capsulesAshbourne Pharmaceuticals Ltd
- United StatesMefenamic acidBryant Ranch Prepack
- SpainCOSLAN 250 MG CAPSULAS DURASPfizer S.L.
- FinlandPonstanWarner Lambert Nordic AB
- CanadaMEFENAMICAA PHARMA INC
- FrancePONSTYL 250 mg, gélulePFIZER HOLDING FRANCE
- SwitzerlandPonstan, HartkapselnPfizer AG
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Mefenam, Parkakut
- Cyprus · Aidol, Alfoxan
- Spain · Coslan
- France · Ponstyl
- United Kingdom (Northern Ireland) · Contraflam, Mefenamic Acid
- Greece · Acinic, Aidol
- Hungary · Ponmel
- Malta · Alfoxan, Mefac
- Romania · Vidan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8cf0e39f-2f4b-4a5b-aef9-9aa9ad647722 GET /v1/drugs/8cf0e39f-2f4b-4a5b-aef9-9aa9ad647722?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"M01AG",
"M01AG01"
],
"strength": null,
"pa_number": "PA0074/015/001",
"substances": [
"Mefenamic acid"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "28/04/1988",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about mefenamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.